Mallinckrodt plc, a global leader in specialty pharmaceuticals, is headquartered in Ireland (IE) and operates extensively across North America and Europe. Founded in 1867, the company has a rich history marked by significant milestones in the development of innovative therapies. Specialising in pain management, autoimmune disorders, and critical care, Mallinckrodt offers a range of unique products, including specialty generics and branded medications. Their commitment to addressing unmet medical needs sets them apart in the competitive pharmaceutical landscape. With a strong market position, Mallinckrodt has achieved notable recognition for its contributions to patient care and has established itself as a trusted name in the industry. The company continues to focus on advancing healthcare solutions that improve the quality of life for patients worldwide.
How does Mallinckrodt plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Mallinckrodt plc's score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Mallinckrodt plc reported total carbon emissions of approximately 89,052,000 kg CO2e for Scope 1 and about 74,164,000 kg CO2e for Scope 2, resulting in a combined total of around 162,999,000 kg CO2e based on a market-based approach. This reflects a slight decrease from 2022, where Scope 1 emissions were about 89,551,000 kg CO2e and Scope 2 emissions were approximately 82,347,000 kg CO2e, leading to a total of around 171,898,000 kg CO2e. Despite these figures, Mallinckrodt has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has reported emissions data for Scope 1 and Scope 2 but has not provided information regarding Scope 3 emissions. As a result, their climate commitments remain unclear, and there are no documented reduction initiatives or pledges available at this time.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | |
---|---|---|
Scope 1 | 89,551,000 | 00,000,000 |
Scope 2 | 82,347,000 | 00,000,000 |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mallinckrodt plc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.